world health organization Archives -

Pierre A. Morgon, PharmD, LL.M, MBA, managing director at CanSino Biologics Europe, tells us about Convidecia, a single

CanSinoBIO developed a highly effective COVID vaccine with an inhalant version

https://pharmaphorum.com/r-d/cansinobio-developed-highly-effective-covid-vaccine-with-inhalant-version/

Patients/ Views & Analysis/ Views and analysis

Studying inequities throughout the pandemic

Jessica Hagen COVID-19, vaccines, WHO, world health organization 0 Comment

Alain Labrique, PhD, professor and associate chair of research at Johns Hopkins Bloomberg School of Public Health (JHSPH)

Studying inequities throughout the pandemic

https://pharmaphorum.com/patients/studying-inequities-throughout-the-pandemic/

Market Access/ R&D/ Views & Analysis/ Views & Analysis/ Views and analysis

Oslo Medicines Initiative asks how to balance innovation incentivisation with security of access

Amanda Barrell Oslo Medicines Initiative, world health organization 0 Comment

Access to medicines is “one of the most challenging policy areas in every country in the European region”

Oslo Medicines Initiative asks how to balance innovation incentivisation with security of access

https://pharmaphorum.com/views-analysis-market-access/oslo-medicines-initiative-balance-innovation-incentivisation-with-security-of-access/

Charities bankroll coronavirus drug hunt as outbreak hits economies

Digital/ News/ News

UK has no plans to buy rapid COVID-19 test favoured by US and WHO

Richard Staines Abbott, COVID-19, world health organization 0 Comment

The US and some of the world’s poorest countries may get a low-cost and rapid COVID-19 test ahead

UK has no plans to buy rapid COVID-19 test favoured by US and WHO

https://pharmaphorum.com/news/uk-has-no-plans-to-buy-rapid-covid-19-test-favoured-by-us-and-who/

News/ News/ R&D

AZ’s COVID-19 vaccine trial pause a ‘wake-up call’ – WHO

Richard Staines AstraZeneca, coronavirus, COVID-19, vaccine, world health organization 0 Comment

AstraZeneca’s pause of its COVID-19 vaccine trial is a “wake-up call” demonstrating the challenges of the development process,

AZ’s COVID-19 vaccine trial pause a ‘wake-up call’ – WHO

https://pharmaphorum.com/news/azs-covid-19-vaccine-trial-pause-a-wake-up-call-who/

News/ News/ R&D

WHO restarts trial of COVID-19 drug hydroxychloroquine

Richard Staines coronavirus, COVID-19, hydroxychloroquine, R&D, world health organization 0 Comment

The World Health Organization has restarted its trial of COVID-19 drug hydroxychloroquine, the malaria drug favoured by president Donald Trump, after a temporary

WHO restarts trial of COVID-19 drug hydroxychloroquine

https://pharmaphorum.com/news/who-restarts-trial-of-covid-19-drug-hydroxychloroquine/

Deep Dive/ Digital/ Market Access

Bringing gene therapies to market

mike.hammerton@pharmaphorum.com bluebird bio, Deep Dive: Access and Commercialisation, gene therapy, Rare diseases, world health organization 0 Comment

Doug Danison, vice-president, head of access, value and evidence strategy at bluebird bio, a gene therapy company, looks

Bringing gene therapies to market

https://pharmaphorum.com/digital/bringing-gene-therapies-to-market/

Digital/ News/ News

WHO releases first guidelines on digital health

George Underwood WHO, world health organization 0 Comment

The World Health Organization (WHO) has released new recommendations on ways that countries can use digital health technology

WHO releases first guidelines on digital health

https://pharmaphorum.com/news/who-releases-first-guidelines-on-digital-health/

Trending

world health organization

Login